Literature DB >> 23251862

Two cases of zolpidem-associated homicide.

Cheryl M Paradis1, Lawrence A Siegel, Stuart B Kleinman.   

Abstract

Zolpidem is the most commonly prescribed medication for the short-term treatment of insomnia. Adverse reactions include nightmares, confusion, and memory deficits. Reported rare adverse neuropsychiatric reactions include sensory distortions such as hallucinations. Previous research has identified 4 factors that may place a patient at increased risk of zolpidem-associated psychotic or delirious reactions: (1) concomitant use of a selective serotonin reuptake inhibitor (SSRI), (2) female gender, (3) advanced age, and (4) zolpidem doses of 10 mg or higher. In this article, 2 cases are presented in which individuals killed their spouses and claimed total or partial amnesia. Neither individual had a history of aggressive behavior. Both had concomitantly taken 10 mg or more of zolpidem in addition to an SSRI (paroxetine).

Entities:  

Year:  2012        PMID: 23251862      PMCID: PMC3505131          DOI: 10.4088/PCC.12br01363

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN: 2155-7780


  23 in total

1.  Psychotic reactions to zolpidem.

Authors:  M Ansseau; W Pitchot; M Hansenne; A Gonzalez Moreno
Journal:  Lancet       Date:  1992-03-28       Impact factor: 79.321

2.  Zolpidem-induced agitation and disorganization.

Authors:  C L Hoyler; J L Tekell; J A Silva
Journal:  Gen Hosp Psychiatry       Date:  1996-11       Impact factor: 3.238

3.  Zolpidem and hallucinations.

Authors:  J S Markowitz; L J Rames; N Reeves; S G Thomas
Journal:  Ann Emerg Med       Date:  1997-02       Impact factor: 5.721

4.  Memory functions as affected by electroconvulsive therapy.

Authors:  L R Squire
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

5.  Possible paroxetine-zolpidem interaction.

Authors:  S E Katz
Journal:  Am J Psychiatry       Date:  1995-11       Impact factor: 18.112

6.  Dose-related sensory distortions with zolpidem.

Authors:  R W Pies
Journal:  J Clin Psychiatry       Date:  1995-01       Impact factor: 4.384

Review 7.  "I did what?" Zolpidem and the courts.

Authors:  Christopher Daley; Dale E McNiel; Renée L Binder
Journal:  J Am Acad Psychiatry Law       Date:  2011

8.  Zolpidem-induced psychosis.

Authors:  J S Markowitz; T D Brewerton
Journal:  Ann Clin Psychiatry       Date:  1996-06       Impact factor: 1.567

Review 9.  Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications.

Authors:  P Salvà; J Costa
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447

10.  Zolpidem in insomnia: a 3-year post-marketing surveillance study in Switzerland.

Authors:  E Ganzoni; J P Santoni; V Chevillard; M Sébille; B Mathy
Journal:  J Int Med Res       Date:  1995 Jan-Feb       Impact factor: 1.671

View more
  3 in total

1.  Zolpidem-induced suicide attempt: a case report.

Authors:  Sameh Mortaz Hejri; Mehrdad Faizi; Mohammad Babaeian
Journal:  Daru       Date:  2013-12-20       Impact factor: 3.117

2.  Zolpidem for Insomnia: A Double-Edged Sword. A Systematic Literature Review on Zolpidem-Induced Complex Sleep Behaviors.

Authors:  Niti Mittal; Rakesh Mittal; M C Gupta
Journal:  Indian J Psychol Med       Date:  2021-03-09

3.  Managing insomnia: an overview of insomnia and pharmacologic treatment strategies in use and on the horizon.

Authors:  Thomas L Schwartz; Viral Goradia
Journal:  Drugs Context       Date:  2013-10-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.